Gordon Naylor
executiveMale0.0Global Dominance: 0.00%
Gordon Naylor is the interim chief executive of CSL, an Australian biotechnology firm, who stepped into the role amid significant challenges for the company, including a $1.5 billion writedown and a sharp decline in share value attributed to regulatory changes and declining vaccination rates in the US.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Gordon Naylor is the interim boss of CSL following the retirement of Paul McKenzie.
Claudia Karvan to headline UniSuper International Women’s Day event at venue accused of exploiting womenThe Sydney Morning Herald·
Australia· 2026-02-11
Australia· 2026-02-11
CSL’s interim chief executive, Gordon Naylor, said on Wednesday that his appointment will not be a passive one.
RFK policies wipe $10 billion wiped off biotech giant’s valueThe Sydney Morning Herald·Australia· 2026-02-11
Australia· 2026-02-11
